NRG-GI002: A phase II clinical trial platform for total neoadjuvant therapy (TNT) in rectal cancer. Background: In metastatic colorectal cancer with deficient DNA mismatch repair (MMR), anti-PD-1 ...
Pathologic complete response (pCR) after neoadjuvant treatment in rectal cancer: Multi-institutional results in Spain. Background: Impact of the preventive oral glutamine intake on the development of ...
FOLFOX is a combination of chemotherapy drugs that can treat colorectal cancer and some other cancers. FOLFOX chemotherapy combines folinic acid, fluorouracil, and oxaliplatin. There are various types ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results